Logo image of GRAL

GRAIL INC (GRAL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GRAL - US3847471014 - Common Stock

108.73 USD
+1.04 (+0.97%)
Last: 11/26/2025, 2:11:21 PM
Fundamental Rating

4

GRAL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 533 industry peers in the Biotechnology industry. GRAL has a great financial health rating, but its profitability evaluates not so good. GRAL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GRAL had negative earnings in the past year.
GRAL had a negative operating cash flow in the past year.
GRAL had negative earnings in each of the past 5 years.
GRAL had a negative operating cash flow in each of the past 5 years.
GRAL Yearly Net Income VS EBIT VS OCF VS FCFGRAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2021 2022 2023 2024 -1B -2B -3B -4B -5B

1.2 Ratios

The Return On Assets of GRAL (-16.39%) is better than 79.74% of its industry peers.
With an excellent Return On Equity value of -19.14%, GRAL belongs to the best of the industry, outperforming 85.18% of the companies in the same industry.
Industry RankSector Rank
ROA -16.39%
ROE -19.14%
ROIC N/A
ROA(3y)-71.58%
ROA(5y)N/A
ROE(3y)-79.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRAL Yearly ROA, ROE, ROICGRAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

GRAL's Gross Margin of 43.18% is fine compared to the rest of the industry. GRAL outperforms 73.92% of its industry peers.
GRAL's Gross Margin has improved in the last couple of years.
GRAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.32%
GM growth 5YN/A
GRAL Yearly Profit, Operating, Gross MarginsGRAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

7

2. Health

2.1 Basic Checks

GRAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GRAL has been increased compared to 1 year ago.
Compared to 5 years ago, GRAL has less shares outstanding
GRAL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GRAL Yearly Shares OutstandingGRAL Yearly Shares OutstandingYearly Shares Outstanding 2019 2021 2022 2023 2024 20M 40M 60M 80M 100M
GRAL Yearly Total Debt VS Total AssetsGRAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

GRAL has an Altman-Z score of 0.38. This is a bad value and indicates that GRAL is not financially healthy and even has some risk of bankruptcy.
GRAL's Altman-Z score of 0.38 is fine compared to the rest of the industry. GRAL outperforms 62.85% of its industry peers.
GRAL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC8.68%
GRAL Yearly LT Debt VS Equity VS FCFGRAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 9.23 indicates that GRAL has no problem at all paying its short term obligations.
GRAL's Current ratio of 9.23 is fine compared to the rest of the industry. GRAL outperforms 79.92% of its industry peers.
A Quick Ratio of 9.20 indicates that GRAL has no problem at all paying its short term obligations.
The Quick ratio of GRAL (9.20) is better than 79.74% of its industry peers.
Industry RankSector Rank
Current Ratio 9.23
Quick Ratio 9.2
GRAL Yearly Current Assets VS Current LiabilitesGRAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

GRAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.18%, which is quite impressive.
The Revenue for GRAL has decreased by -21.40% in the past year. This is quite bad
The Revenue has been growing by 104.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)90.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.56%
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y104.84%
Revenue growth 5YN/A
Sales Q2Q%26.33%

3.2 Future

GRAL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.97% yearly.
The Revenue is expected to grow by 20.47% on average over the next years. This is a very strong growth
EPS Next Y79.85%
EPS Next 2Y34.51%
EPS Next 3Y22.31%
EPS Next 5Y12.97%
Revenue Next Year16.69%
Revenue Next 2Y18.51%
Revenue Next 3Y18.36%
Revenue Next 5Y20.47%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GRAL Yearly Revenue VS EstimatesGRAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
GRAL Yearly EPS VS EstimatesGRAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GRAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GRAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRAL Price Earnings VS Forward Price EarningsGRAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRAL Per share dataGRAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

GRAL's earnings are expected to grow with 22.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.51%
EPS Next 3Y22.31%

More info and screens

0

5. Dividend

5.1 Amount

GRAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GRAIL INC

NASDAQ:GRAL (11/26/2025, 2:11:21 PM)

108.73

+1.04 (+0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)01-19 2026-01-19
Inst Owners73.62%
Inst Owner Change-4.57%
Ins Owners1.32%
Ins Owner Change-22.02%
Market Cap3.92B
Revenue(TTM)141.83M
Net Income(TTM)-442.95M
Analysts76
Price Target91.8 (-15.57%)
Short Float %17.43%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.27%
Min EPS beat(2)12.61%
Max EPS beat(2)25.93%
EPS beat(4)4
Avg EPS beat(4)20.78%
Min EPS beat(4)1.96%
Max EPS beat(4)42.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.28%
Min Revenue beat(2)-11.33%
Max Revenue beat(2)-7.24%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)122.22%
PT rev (3m)122.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.83%
EPS NY rev (1m)0%
EPS NY rev (3m)4.37%
Revenue NQ rev (1m)4.63%
Revenue NQ rev (3m)4.63%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 29.19
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 9.93
EV/EBITDA N/A
EPS(TTM)-11.64
EYN/A
EPS(NY)-12.97
Fwd EYN/A
FCF(TTM)-10.31
FCFYN/A
OCF(TTM)-10.26
OCFYN/A
SpS3.72
BVpS64.21
TBVpS10.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.39%
ROE -19.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.18%
FCFM N/A
ROA(3y)-71.58%
ROA(5y)N/A
ROE(3y)-79.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.32%
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.09%
Cap/Sales 1.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.23
Quick Ratio 9.2
Altman-Z 0.38
F-Score5
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)8.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)19.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.56%
EPS Next Y79.85%
EPS Next 2Y34.51%
EPS Next 3Y22.31%
EPS Next 5Y12.97%
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y104.84%
Revenue growth 5YN/A
Sales Q2Q%26.33%
Revenue Next Year16.69%
Revenue Next 2Y18.51%
Revenue Next 3Y18.36%
Revenue Next 5Y20.47%
EBIT growth 1Y3.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year82.82%
EBIT Next 3Y22.61%
EBIT Next 5Y13.55%
FCF growth 1Y4.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.13%
OCF growth 3YN/A
OCF growth 5YN/A

GRAIL INC / GRAL FAQ

Can you provide the ChartMill fundamental rating for GRAIL INC?

ChartMill assigns a fundamental rating of 4 / 10 to GRAL.


What is the valuation status for GRAL stock?

ChartMill assigns a valuation rating of 1 / 10 to GRAIL INC (GRAL). This can be considered as Overvalued.


How profitable is GRAIL INC (GRAL) stock?

GRAIL INC (GRAL) has a profitability rating of 2 / 10.


What is the earnings growth outlook for GRAIL INC?

The Earnings per Share (EPS) of GRAIL INC (GRAL) is expected to grow by 79.85% in the next year.